The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abeona Therapeutics Inc. | COM | 00289Y107 | 3,340 | 1,590,686 | SH | SOLE | 1,590,686 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 1,770,469 | 41,904,586 | SH | SOLE | 41,904,586 | 0 | 0 | ||
Acceleron Pharma Inc. | COM | 00434H108 | 2,426 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 499 | 172,630 | SH | SOLE | 172,630 | 0 | 0 | ||
Adaptive Biotechnologies Corporation | COM | 00650F109 | 20,661 | 743,734 | SH | SOLE | 743,734 | 0 | 0 | ||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 10,038 | 3,690,307 | SH | SOLE | 3,690,307 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 7,985 | 1,713,604 | SH | SOLE | 1,713,604 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 316 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 9,718 | 673,908 | SH | SOLE | 673,908 | 0 | 0 | ||
Albireo Pharma, Inc. | COM | 01345P106 | 6,041 | 369,047 | SH | SOLE | 369,047 | 0 | 0 | ||
Alector, Inc. | COM | 014442107 | 6,756 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 786,632 | 8,760,794 | SH | SOLE | 8,760,794 | 0 | 0 | ||
Alkermes plc | SHS | G01767105 | 17,949 | 1,244,744 | SH | SOLE | 1,244,744 | 0 | 0 | ||
Allakos Inc. | COM | 01671P100 | 32,721 | 735,469 | SH | SOLE | 735,469 | 0 | 0 | ||
Amarin Corporation plc | SPONSORED ADR | 023111206 | 137,987 | 34,496,685 | SH | SOLE | 34,496,685 | 0 | 0 | ||
AnaptysBio, Inc. | COM | 032724106 | 3,315 | 234,592 | SH | SOLE | 234,592 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | COM | 03753U106 | 24,019 | 896,551 | SH | SOLE | 896,551 | 0 | 0 | ||
Applied Therapeutics, Inc. | COM | 03828A101 | 2,155 | 65,934 | SH | SOLE | 65,934 | 0 | 0 | ||
Aravive, Inc. | COM | 03890D108 | 2,801 | 486,333 | SH | SOLE | 486,333 | 0 | 0 | ||
Arcus Biosciences, Inc. | COM | 03969F109 | 1,687 | 121,534 | SH | SOLE | 121,534 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 134,306 | 1,019,557 | SH | SOLE | 1,019,557 | 0 | 0 | ||
ArTara Therapeutics, Inc. | COM | 04300J107 | 4,592 | 199,671 | SH | SOLE | 199,671 | 0 | 0 | ||
ARYA Sciences Acquisition Corp. | SHS CL A | G3165V109 | 1,527 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 381,778 | 3,390,270 | SH | SOLE | 3,390,270 | 0 | 0 | ||
Assembly Biosciences, Inc. | COM | 045396108 | 22,862 | 1,541,618 | SH | SOLE | 1,541,618 | 0 | 0 | ||
Atreca, Inc. | CL A COM | 04965G109 | 58,467 | 3,532,760 | SH | SOLE | 3,532,760 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 24,695 | 1,701,929 | SH | SOLE | 1,701,929 | 0 | 0 | ||
Autolus Therapeutics plc | SPON ADS | 05280R100 | 939 | 156,773 | SH | SOLE | 156,773 | 0 | 0 | ||
Axsome Therapeutics, Inc. | COM | 05464T104 | 52,344 | 889,757 | SH | SOLE | 889,757 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 1,449,902 | 11,777,285 | SH | SOLE | 11,777,285 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 1,173 | 249,123 | SH | SOLE | 249,123 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 21,892 | 10,946,166 | SH | SOLE | 10,946,166 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | COM | 09060J106 | 6,209 | 1,638,334 | SH | SOLE | 1,638,334 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 641,295 | 7,589,294 | SH | SOLE | 7,589,294 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 1,838 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
Cabaletta Bio, Inc. | COM | 12674W109 | 4,645 | 636,363 | SH | SOLE | 636,363 | 0 | 0 | ||
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 4,084 | 1,060,714 | SH | SOLE | 1,060,714 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 63,766 | 13,713,195 | SH | SOLE | 13,713,195 | 0 | 0 | ||
ChemoCentryx, Inc. | COM | 16383L106 | 34,515 | 859,015 | SH | SOLE | 859,015 | 0 | 0 | ||
Constellation Pharmaceuticals, Inc. | COM | 210373106 | 4,191 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 2,573 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
CytomX Therapeutics, Inc. | COM | 23284F105 | 153 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 57,288 | 14,614,264 | SH | SOLE | 14,614,264 | 0 | 0 | ||
Denali Therapeutics Inc. | COM | 24823R105 | 1,837 | 104,900 | SH | SOLE | 104,900 | 0 | 0 | ||
Dicerna Pharmaceuticals, Inc. | COM | 253031108 | 1,505 | 81,935 | SH | SOLE | 81,935 | 0 | 0 | ||
Exact Sciences Corporation | COM | 30063P105 | 107,076 | 1,846,139 | SH | SOLE | 1,846,139 | 0 | 0 | ||
Evofem Biosciences, Inc. | COM | 30048L104 | 3,305 | 621,297 | SH | SOLE | 621,297 | 0 | 0 | ||
Frequency Therapeutics, Inc. | COM | 35803L108 | 21,019 | 1,180,162 | SH | SOLE | 1,180,162 | 0 | 0 | ||
Fulgent Genetics, Inc. | COM | 359664109 | 6,127 | 569,444 | SH | SOLE | 569,444 | 0 | 0 | ||
G1 Therapeutics, Inc. | COM | 3621LQ109 | 970 | 88,026 | SH | SOLE | 88,026 | 0 | 0 | ||
Galapagos NV | SPONSORED ADR | 36315X101 | 2,561 | 13,072 | SH | SOLE | 13,072 | 0 | 0 | ||
Galmed Pharmaceuticals Ltd. | SHS | M47238106 | 746 | 215,594 | SH | SOLE | 215,594 | 0 | 0 | ||
Genfit SA | ADS | 372279109 | 395 | 26,696 | SH | SOLE | 26,696 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | COM | 37890U108 | 2,401 | 47,000 | SH | SOLE | 47,000 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 32,475 | 370,845 | SH | SOLE | 370,845 | 0 | 0 | ||
Harpoon Therapeutics, Inc. | COM | 41358P106 | 2,368 | 204,467 | SH | SOLE | 204,467 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 70,653 | 6,018,104 | SH | SOLE | 6,018,104 | 0 | 0 | ||
HOOKIPA Pharma Inc. | COM | 43906K100 | 5,779 | 700,481 | SH | SOLE | 700,481 | 0 | 0 | ||
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 5,924 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
IDEAYA Biosciences, Inc. | COM | 45166A102 | 522 | 126,611 | SH | SOLE | 126,611 | 0 | 0 | ||
Idera Pharmaceuticals, Inc. | COM PAR | 45168K405 | 6,084 | 4,608,786 | SH | SOLE | 4,608,786 | 0 | 0 | ||
IGM Biosciences, Inc. | COM | 449585108 | 176,536 | 3,144,000 | SH | SOLE | 3,144,000 | 0 | 0 | ||
Immunomedics, Inc. | COM | 452907108 | 4,179 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 2,341,806 | 31,978,785 | SH | SOLE | 31,978,785 | 0 | 0 | ||
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 486 | 580,400 | SH | SOLE | 580,400 | 0 | 0 | ||
Inflarx N.V. | COM | N44821101 | 6,794 | 1,778,415 | SH | SOLE | 1,778,415 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 48,497 | 3,025,384 | SH | SOLE | 3,025,384 | 0 | 0 | ||
Intellia Therapeutics, Inc. | COM | 45826J105 | 1,572 | 128,538 | SH | SOLE | 128,538 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 124,405 | 9,100,615 | SH | SOLE | 9,100,615 | 0 | 0 | ||
IVERIC bio, Inc. | COM | 46583P102 | 5,626 | 1,635,501 | SH | SOLE | 1,635,501 | 0 | 0 | ||
Karuna Therapeutics, Inc. | COM | 48576A100 | 3,022 | 41,976 | SH | SOLE | 41,976 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 43,337 | 2,799,577 | SH | SOLE | 2,799,577 | 0 | 0 | ||
Kodiak Sciences Inc. | COM | 50015M109 | 552,105 | 11,574,538 | SH | SOLE | 11,574,538 | 0 | 0 | ||
Krystal Biotech, Inc. | COM | 501147102 | 40,925 | 946,471 | SH | SOLE | 946,471 | 0 | 0 | ||
Leap Therapeutics, Inc. | COM | 52187K101 | 1,546 | 978,454 | SH | SOLE | 978,454 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 100,087 | 1,499,212 | SH | SOLE | 1,499,212 | 0 | 0 | ||
Marker Therapeutics, Inc. | COM | 57055L107 | 2,793 | 1,470,198 | SH | SOLE | 1,470,198 | 0 | 0 | ||
Matinas BioPharma Holdings, Inc. | COM | 576810105 | 2,253 | 3,754,221 | SH | SOLE | 3,754,221 | 0 | 0 | ||
Menlo Therapeutics Inc. | COM | 586858102 | 1,676 | 625,345 | SH | SOLE | 625,345 | 0 | 0 | ||
Merus N.V. | COM | N5749R100 | 24,653 | 2,037,469 | SH | SOLE | 2,037,469 | 0 | 0 | ||
Millendo Therapeutics, Inc. | COM | 60040X103 | 4,400 | 833,333 | SH | SOLE | 833,333 | 0 | 0 | ||
Minerva Neurosciences, Inc. | COM | 603380106 | 4,145 | 688,531 | SH | SOLE | 688,531 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 108,370 | 1,409,784 | SH | SOLE | 1,409,784 | 0 | 0 | ||
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 8,167 | 583,333 | SH | SOLE | 583,333 | 0 | 0 | ||
Molecular Templates, Inc. | COM | 608550109 | 3,162 | 237,917 | SH | SOLE | 237,917 | 0 | 0 | ||
MyoKardia, Inc. | COM | 62857M105 | 83,176 | 1,774,234 | SH | SOLE | 1,774,234 | 0 | 0 | ||
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 38,666 | 3,397,740 | SH | SOLE | 3,397,740 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 107,343 | 1,240,243 | SH | SOLE | 1,240,243 | 0 | 0 | ||
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 3,083 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 3,055 | 405,702 | SH | SOLE | 405,702 | 0 | 0 | ||
Ovid Therapeutics Inc. | COM | 690469101 | 207 | 69,471 | SH | SOLE | 69,471 | 0 | 0 | ||
Passage Bio, Inc. | COM | 702712100 | 4,331 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
Principia Biopharma Inc. | COM | 74257L108 | 116,112 | 1,955,413 | SH | SOLE | 1,955,413 | 0 | 0 | ||
Protagonist Therapeutics, Inc. | COM | 74366E102 | 11,855 | 1,679,164 | SH | SOLE | 1,679,164 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | COM | 74933V108 | 100,525 | 2,093,839 | SH | SOLE | 2,093,839 | 0 | 0 | ||
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 8,081 | 55,983 | SH | SOLE | 55,983 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 41,219 | 2,708,200 | SH | SOLE | 2,708,200 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | COM | 800677106 | 6,369 | 999,823 | SH | SOLE | 999,823 | 0 | 0 | ||
Seattle Genetics, Inc. | COM | 812578102 | 5,775,950 | 50,060,240 | SH | SOLE | 50,060,240 | 0 | 0 | ||
Sunesis Pharmaceuticals, Inc. | COM PAR | 867328700 | 231 | 556,665 | SH | SOLE | 556,665 | 0 | 0 | ||
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 4,093 | 690,167 | SH | SOLE | 690,167 | 0 | 0 | ||
Tricida, Inc. | COM | 89610F101 | 58,652 | 2,666,015 | SH | SOLE | 2,666,015 | 0 | 0 | ||
uniQure N.V. | SHS | N90064101 | 16,944 | 357,083 | SH | SOLE | 357,083 | 0 | 0 | ||
UroGen Pharma Ltd. | COM | M96088105 | 12,005 | 672,912 | SH | SOLE | 672,912 | 0 | 0 | ||
Urovant Sciences Ltd. | SHS | G9381B108 | 9,220 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
Viking Therapeutics, Inc. | COM | 92686J106 | 1,989 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 12,792 | 428,120 | SH | SOLE | 428,120 | 0 | 0 | ||
Zymeworks Inc. | COM | 98985W102 | 60,600 | 1,708,472 | SH | SOLE | 1,708,472 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | 15,576 | 15,000,000 | PRN | SOLE | 15,000,000 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | 39,321 | 30,770,000 | PRN | SOLE | 30,770,000 | 0 | 0 |